APOE and synucleinopathy: There are no studies associating APOE4 with altered risk of suffering oligodendrocytic synucleinopathy multiple system atrophy (MSA), although astrocyte-secreted apoE4 unexpectedly was found to reduce the uptake of α-synuclein in cultures of oligodendrocytic cells [682].